Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD

Clinical trial NCT00382616 · COMPLETED

Trial details

NCT number: NCT00382616
Sponsor: Tel-Aviv Sourasky Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder

Start date: 2004-07-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.